1.
Qin P, Huang C, Jiang B, et al. Dietary carbohydrate quantity and quality and risk of cardiovascular disease, all-cause, cardiovascular and cancer mortality: a systematic review and meta-analysis. Clin Nutr. 2023;42(2):148-165.
2.
Gaidai O, Cao Y, Loginov S. Global cardiovascular diseases death rate prediction. Curr Probl Cardiol. 2023;48(5):101622.
3.
Çevik S, Akman M. Frequency and risk assessment of cardiovascular diseases in the world and Turkey. J Turkish Fam Physician. 2022;13(1):21-28.
4.
Jamison DT, Summers LH, Chang AY, et al. Global health 2050: the path to halving premature death by mid-century. Lancet. 2024; 404(10462):1561-1614.
5.
Gonçalves-Martins G, Gil-Sala D, Tello-Díaz C, et al. Prevalence of peripheral arterial disease and associated vascular risk factors in 65-years-old people of Northern Barcelona. J Clin Med. 2021;10(19):4467.
6.
Wittens C, Davies A, Bækgaard N, et al. Editor’s choice-management of chronic venous disease: clinical practice guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2015; 49(6):678-737.
7.
Gil-Montoya JA, de Mello ALF, Barrios R, et al. Oral health in the elderly patient and its impact on general well-being: a nonsystematic review. Clin Interv Aging. 2015;10:461-467.
8.
Ahmad W, Alharthy RD, Zubair M, et al. Toxic and heavy metals contamination assessment in soil and water to evaluate human health risk. Sci Rep. 2021;11(1):17006.
9.
Nucera S, Serra M, Caminiti R, et al. Non-essential heavy metal effects in cardiovascular diseases: an overview of systematic reviews. Front Cardiovasc Med. 2024;11:1332339.
10.
Pan Z, Gong T, Liang P. Heavy metal exposure and cardiovascular disease. Circ Res. 2024;134(9):1160-1178.
11.
Prozialeck WC, Edwards JR, Nebert DW, et al. The vascular system as a target of metal toxicity. Toxicol Sci. 2008;102(2):207-218.
12.
He J, Wang M, Jiang Y, et al. Chronic arsenic exposure and angiogenesis in human bronchial epithelial cells via the ROS/miR-199a-5p/HIF-1α/COX-2 pathway. Environ Health Perspect. 2014;122(3):255-261.
13.
Wei T, Jia J, Wada Y, et al. Dose dependent effects of cadmium on tumor angiogenesis. Oncotarget. 2017;8(27):44944-44959.
14.
Tsoi MF, Lo CWH, Cheung TT, et al. Blood lead level and risk of hypertension in the United States National Health And Nutrition Examination Survey 1999-2016. Sci Rep. 2021;11(1):3010.
15.
Lamas GA, Bhatnagar A, Jones MR, et al. Contaminant metals as cardiovascular risk factors: a scientific statement from the American Heart Association. J Am Heart Assoc. 2023;12(13):e029852.
16.
Turksoy VA, Yalvac ES, Simsek OT, et al. Impact of zinc on birth and placental weight in cadmium and lead exposure during pregnancy. Indian J Forensic Med Pathol. 2019; 12(3):246-254.
17.
Paithankar JG, Saini S, Dwivedi S, et al. Heavy metal associated health hazards: an interplay of oxidative stress and signal transduction. Chemosphere. 2021;262:128350.
18.
Sevim Ç, Doğan E, Comakli S. Cardiovascular disease and toxic metals. Curr Opin Toxicol. 2020;19:88-92.
19.
Dugani S, Gaziano TA. 25 by 25: achieving global reduction in cardiovascular mortality. Curr Cardiol Rep. 2016;18(1):10.
20.
Solenkova NV, Newman JD, Berger JS, Thurston G, Hochman JS, Lamas GA. Metal pollutants and cardiovascular disease: mechanisms and consequences of exposure.Am Heart J. 2014;168(6):812-822.
21.
Yerli C, Cakmakcı T, Sahin U, et al. The Effects of heavy metals on soil, plant, water and human health. Turkish J Nat Sci. 2020;9:103-114.
22.
Aschner M, Erikson KM, Hernández EH, et al. Manganese and its role in Parkinson’s disease: from transport to neuropathology. Neuromolecular Med. 2009;11(4):252-266.
23.
Turksoy VA, Tutkun L, Gunduzoz M, et al. Changing levels of selenium and zinc in cadmium-exposed workers: probable association with the intensity of inflammation. Mol Biol Rep. 2019;46(5):5455-5464.
24.
Begum F, Me HM, Christov M. The role of zinc in cardiovascular disease. Cardiol Rev. 2022;30(2):100-108.
25.
Shin MY, Kwun IS. Zinc restored the decreased vascular smooth muscle cell viability under atherosclerotic calcification conditions. Prev Nutr Food Sci. 2014;19(4):363-366.
26.
Voelkl J, Tuffaha R, Luong TTD, et al. Zinc ınhibits phosphate-ınduced vascular calcification through TNFAIP3-mediated suppression of NF- κ B. J Am Soc Nephrol. 2018;29(6):1636-1648.
27.
Chen W, Eisenberg R, Mowrey WB, et al. Association between dietary zinc intake and abdominal aortic calcification in US adults. Nephrol Dial Transplant. 2020;35(7):1171-1178.
28.
Houston MC. Role of mercury toxicity in hypertension, cardiovascular disease, and stroke. J Clin Hypertens (Greenwich). 2011;13(8):621-627.
29.
Hu XF, Lowe M, Chan HM. Mercury exposure, cardiovascular disease, and mortality: a systematic review and dose-response meta-analysis. Environ Res. 2021;193:110538.
30.
Lin CH, Hsu YT, Yen CC, et al. Association between heavy metal levels and acute ischemic stroke. J Biomed Sci. 2018;25(1):49.
31.
Ikediobi CO, Badisa VL, Ayuk-Takem LT, et al. Response of antioxidant enzymes and redox metabolites to cadmium-induced oxidative stress in CRL-1439 normal rat liver cells. Int J Mol Med. 2004;14(1):87-92.
32.
Prozialeck WC, Edwards JR, Woods JM. The vascular endothelium as a target of cadmium toxicity. Life Sci. 2006;79(16):1493-1506.
33.
Kishimoto T, Ueda D, Isobe M, et al. Cadmium injures tube formation by cultured human vascular endothelial cells. Hum Cell. 1996;9(3):244-250.
34.
Harlan WR. The relationship of blood lead levels to blood pressure in the U.S. population. Environ Health Perspect. 1988;78:9-13.
35.
Nunes FL da S, Lima SCVC, Lyra C de O, et al. The impact of essential and toxic elements on cardiometabolic risk factors in adults and older people. J Trace Elem Med Biol. 2022;72:126991.
36.
Miller M, Stone NJ, Ballantyne C, et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2011;123(20):2292-2333.
37.
Liu Y, Geng T, Wan Z, et al. Associations of serum folate and vitamin B12 levels with cardiovascular disease mortality among patients with type 2 diabetes. JAMA Netw Open. 2022;5(1):e2146124.
38.
Li Y, Huang T, Zheng Y, et al. Folic acid supplementation and the risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. J Am Heart Assoc. 2016;5(8):e003768.
39.
Møller L, Kristensen TS. Blood lead as a cardiovascular risk factor. Am J Epidemiol. 1992;136(9):1091-1100.
40.
Kim JH, Byun HM, Chung EC, et al. Loss of ıntegrity: ımpairment of the blood-brain barrier in heavy metal-associated ıschemic stroke. Toxicol Res. 2013;29(3):157-164.
41.
Mitra J, Vasquez V, Hegde PM, et al. Revisiting metal toxicity in neurodegenerative diseases and stroke: therapeutic potential. Neurol Res Ther. 2014;1(2):107. doi:10.14437/NRTOA-1-107
42.
Prozialeck WC, Edwards JR, Nebert DW, et al. The vascular system as a target of metal toxicity. Toxicol Sci. 2008;102(2):207-218.
43.
Kaji T. Cell biology of heavy metal toxicity in vascular tissue. J Pharm Soc Japan. 2004;124(3):113-120.